A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)
University of California, San Francisco
University of California, San Francisco
City of Hope Medical Center
University of South Florida
INSYS Therapeutics Inc